Future options for treating schizophrenia Gill Higgins Newsletter Article 13 February 2013 Pages: 3 - 6
SSRIs - expanding the choice of treatment in depression Gill Higgins Newsletter Article 13 February 2013 Pages: 6 - 8
Cutting down cholesterol - costs, savings and implications Newsletter Article 13 February 2013 Pages: 9 - 9
Implantable cardioverter-defibrillator vs amiodarone Newsletter Article 13 February 2013 Pages: 10 - 10
Sulfonic acid polymers potently and selectively inhibit HIV replication Newsletter Article 13 February 2013 Pages: 11 - 11
First study in humans for Merck & Co’s novel antiarrhythmic L-691,121 Newsletter Article 13 February 2013 Pages: 13 - 13
Yoshotomi’s new potassium channel activator with less tachycardia Newsletter Article 13 February 2013 Pages: 13 - 13
Olsalazine superior to mesalazine in ulcerative colitis Newsletter Article 13 February 2013 Pages: 14 - 15
Clarifying the efficacy of whole-cell pertussis vaccination Newsletter Article 13 February 2013 Pages: 15 - 15
Looking to the future in anxiety disorders - conference report Tom Lavelle Newsletter Article 13 February 2013 Pages: 16 - 17
Erythromycin - estolate has advantages over ethylsuccinate Newsletter Article 13 February 2013 Pages: 18 - 19
Increasing gastric pH increases the risk of pneumonia Newsletter Article 13 February 2013 Pages: 20 - 20
Tocopherol shows promise in antineoplastic-induced mucositis Newsletter Article 13 February 2013 Pages: 22 - 22